Institute
Our objective is to discover, validate and target novel pathomechanisms and molecular signals for the development of personalized preventive and therapeutic strategies for diabetes, obesity and co-morbidities such as cancer and cardiovascular disease. The IDO currently comprises 14 research groups and the Neurobiology Research Unit headed by Dr. Pfluger. The IDO is part of the Helmholtz Diabetes Center (HDC).